// App-Quantinova.ai

84 P-2-209 : Sclerostin and Its Associations with Energy Metabolism in Children and Adolescents

Researchers

Presenter

  • Anna Wedrychowicz

Principal Investigators

  • Jerzy Starzyk

Medical Centers

  • Department of Pediatric and Adolescent Endocrinology, Polish-American Pediatric Institute, Medical College, Jagiellonian University, Cracow, Poland

Locations

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • Type 1 diabetes mellitus

  • Obesity

Biomarkers

  • Receptor activator of nuclear factor kappa-Β ligand

  • Hemoglobin A1c

  • Sclerostin

Drug/Treatment

  • Ergocalciferol

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final